Literature DB >> 30970197

Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.

David Henley1, Nandini Raghavan1, Reisa Sperling2, Paul Aisen3, Rema Raman3, Gary Romano4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30970197     DOI： 10.1056/NEJMc1813435

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

1.  Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data.

Authors:  Clément Abi Nader; Nicholas Ayache; Giovanni B Frisoni; Philippe Robert; Marco Lorenzi
Journal:  Brain Commun       Date:  2021-04-28

Review 2.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 3.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

4.  Early Intervention in Alzheimer's Disease: How Early is Early Enough?

Authors:  Dong-Yu Fan; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2019-09-07       Impact factor: 5.203

5.  Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life.

Authors:  Lei Liu; Bianca M Lauro; Li Ding; Matteo Rovere; Michael S Wolfe; Dennis J Selkoe
Journal:  Alzheimers Dement       Date:  2019-08-12       Impact factor: 21.566

Review 6.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 7.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 8.  Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.

Authors:  Ariel J Kuhn; Jevgenij Raskatov
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Alzheimer's Disease "Non-amyloidogenic" p3 Peptide Revisited: A Case for Amyloid-α.

Authors:  Ariel J Kuhn; Benjamin S Abrams; Stella Knowlton; Jevgenij A Raskatov
Journal:  ACS Chem Neurosci       Date:  2020-05-22       Impact factor: 4.418

Review 10.  The β-Secretase BACE1 in Alzheimer's Disease.

Authors:  Harald Hampel; Robert Vassar; Bart De Strooper; John Hardy; Michael Willem; Neeraj Singh; John Zhou; Riqiang Yan; Eugeen Vanmechelen; Ann De Vos; Robert Nisticò; Massimo Corbo; Bruno Pietro Imbimbo; Johannes Streffer; Iryna Voytyuk; Maarten Timmers; Amir Abbas Tahami Monfared; Michael Irizarry; Bruce Albala; Akihiko Koyama; Naoto Watanabe; Teiji Kimura; Lisa Yarenis; Simone Lista; Lynn Kramer; Andrea Vergallo
Journal:  Biol Psychiatry       Date:  2020-02-13       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.